Additive Effects of Genetic Interleukin‐6 Signaling Downregulation and Low‐Density Lipoprotein Cholesterol Lowering on Cardiovascular Disease: A 2×2 Factorial Mendelian Randomization Analysis

BACKGROUND: Although trials suggest that anti‐inflammatory approaches targeting interleukin (IL)‐6 signaling can reduce cardiovascular risk, it remains unknown whether targeting IL‐6 signaling could reduce risk additively to low‐density lipoprotein cholesterol (LDL‐C) lowering. Here, we assess inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Georgakis, Marios K., Malik, Rainer, Burgess, Stephen, Dichgans, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075213/
https://www.ncbi.nlm.nih.gov/pubmed/34927447
http://dx.doi.org/10.1161/JAHA.121.023277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075213/
https://www.ncbi.nlm.nih.gov/pubmed/34927447
http://dx.doi.org/10.1161/JAHA.121.023277

Ejemplares similares